Skip navigation

T3 Pharmaceuticals wins highest endowed award for startup companies in Switzerland

Salome Grisard Varnholt (1.v.l.), Andrea Grisard (2.v.l.) and Felix Grisard (4.v.l.), the donators of the price, together with Regula Buob (2.v.r.) and Beat Graf (1.v.r.) from the W.A. de Vigier Foundation present the W.A. de Vigier Award 2019 to Dr. Simon Ittig, CEO of T3 Pharma. (Image: W.A. de Vigier Foundation)

Our mission

T3 Pharmaceuticals is a pre-clinical biopharmaceutical company working to advance new generation therapies for cancer patients. Our dedicated team is developing highly specific and efficient treatments using live bacteria.